Performance & Vitality · Reviewed by Ian K. Tseng, MD
Sildenafil vs. Tadalafil: How PDE5 Inhibitors Work
Sildenafil and tadalafil are not peptides either — they are small-molecule drugs in a class called PDE5 inhibitors, and they sit in the intimate-wellness portion of the program. They share a mechanism and differ substantially in one property: how long they last. That single difference drives most of the clinical decision between them.
Published August 4, 2026 · Medical review by Ian K. Tseng, MD, Medical Director
The short answer
Sildenafil and tadalafil are phosphodiesterase type 5 inhibitors. Both work by blocking the enzyme that breaks down cyclic GMP, allowing cGMP to accumulate, smooth muscle to relax, and blood flow to increase in the relevant tissue. The clinically important difference is duration: sildenafil has a half-life of roughly four hours, tadalafil approximately seventeen and a half. Both are FDA-approved as tablets; orally disintegrating formulations are compounded.
The shared mechanism
Erectile function depends on a nitric oxide signaling cascade. Sexual stimulation triggers nitric oxide release in the relevant tissue, which raises levels of cyclic guanosine monophosphate — cGMP. Elevated cGMP relaxes the smooth muscle of the arteries supplying the tissue, increasing blood flow.
The enzyme phosphodiesterase type 5 degrades cGMP, which is how the response resolves. PDE5 inhibitors block that enzyme, so cGMP persists longer and the vasodilatory effect is sustained.
A consequence that follows directly from the mechanism, and that patients frequently misunderstand: these medications do not initiate the response. They amplify and prolong a cascade that sexual stimulation starts. Without that trigger, there is no nitric oxide release, no cGMP elevation, and nothing for the drug to preserve.
The half-life difference and what it means
Sildenafil has a half-life of approximately four hours. It is taken in anticipation of activity, typically within a defined window beforehand, and its effect is correspondingly time-bounded. Absorption is meaningfully slowed by a high-fat meal.
Tadalafil has a half-life of roughly seventeen and a half hours, which produces a substantially longer window of effect and supports a different usage pattern — including lower-dose daily regimens where the goal is continuous availability rather than timed dosing. Food has less effect on its absorption.
Neither profile is superior in the abstract. The choice depends on how a patient actually wants to use the medication, alongside their medical history and other medications — which is what the clinical evaluation is for.
Contraindications that are not negotiable
The most important is absolute: PDE5 inhibitors must not be combined with nitrate medications in any form — including nitroglycerin for chest pain, isosorbide preparations, and recreational nitrites sometimes called "poppers." Both act as vasodilators through overlapping pathways, and the combination can produce a severe, potentially life-threatening drop in blood pressure. This is not a caution to be managed; it is a contraindication.
Alpha-blockers, commonly prescribed for benign prostatic hyperplasia or hypertension, require careful timing and dose consideration for related reasons. Significant cardiovascular disease warrants evaluation before prescribing, in part because sexual activity itself carries cardiac demand.
Additional considerations include a history of non-arteritic anterior ischemic optic neuropathy, certain retinal conditions, severe hepatic or renal impairment, and specific drug interactions. Every one of these is screened during the Good Faith Exam — which is why this category, despite how casually it is sold online, is a prescription category.
What the compounded ODT form changes
Sildenafil and tadalafil are FDA-approved as conventional oral tablets. An orally disintegrating tablet — ODT — is a compounded formulation designed to dissolve in the mouth without water.
The reasons for preferring that form are practical: swallowing difficulty, convenience, discretion. The compounded ODT has not been through FDA pre-market review in that form, which is the relevant regulatory distinction and the reason the compounded-medication disclaimer applies here as it does elsewhere in the program.
Related reading
About compounded medications
Compounded medications do not undergo pre-market review or an FDA-approval process. They may differ from commercially available or FDA-approved drugs in efficacy, safety, risk, and side-effect profiles. Data from clinical trials on FDA-approved medications should not be used to make assessments related to compounded medications.
Curious whether this fits your goals?
A $50 Application covers the full intake: a secure health-history form, a brief telehealth Good Faith Exam, and medical clearance. Not everyone qualifies, and we will tell you if you do not.
Start Your $50 ApplicationFrequently asked questions
How do PDE5 inhibitors work?
What is the difference between sildenafil and tadalafil?
What should never be combined with a PDE5 inhibitor?
What is an orally disintegrating tablet?
Clinical references
Medically reviewed by Ian K. Tseng, MD, Medical Director of Soothe IV's peptide therapy program. The clinical statements in this article are supported by the following sources:
- Huang SA, Lie JD. Phosphodiesterase-5 (PDE5) Inhibitors In the Management of Erectile Dysfunction. Pharmacy and Therapeutics. 2013. pmc.ncbi.nlm.nih.gov
- Smith BP, Babos M. Sildenafil. StatPearls. 2023. www.ncbi.nlm.nih.gov
- U.S. Food & Drug Administration. Human Drug Compounding. www.fda.gov
Ready to talk to a physician?
Start your $50 Application — the comprehensive intake, physician Good Faith Examination, and medical clearance. A physician reviews your goals and labs and tells you honestly whether therapy is appropriate. Your fee credits in full toward your first month of membership. Available nationwide.
Book & Pay for Your $50 ApplicationServing Orange County, Los Angeles, and San Diego — plus nationwide telehealth. All service areas.
This article is educational and is not medical advice. Statements have not been evaluated by the FDA. Peptide therapy is a physician-supervised medical service; specific protocols are determined individually after a Good Faith Examination and bloodwork, and not all applicants qualify. Some compounded medications used in physician-prescribed protocols are not FDA-approved. Data from clinical trials on FDA-approved medications should not be used to make assessments related to compounded medications. Soothe IV's peptide program is available nationwide via telehealth; prescriptions are issued by physicians licensed in your state.